Literature DB >> 24833355

How I treat sinusoidal obstruction syndrome.

Nelson Chao1.   

Abstract

Sinusoidal obstruction syndrome (SOS), previously called veno-occlusive disease (VOD) can be a difficult problem after hematopoietic cell transplantation (HCT). The overall incidence has changed since the early days of allogeneic HCT. Prophylaxis and treatment remain important components of supportive care. As the indication and the comorbidities for HCT continue to change, especially with older and more infirm patients, SOS remains an important area for clinicians. I discuss how SOS could be addressed, from prophylaxis to diagnosis and potential therapy.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2014        PMID: 24833355     DOI: 10.1182/blood-2014-03-551630

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Authors:  Ayman Akil; Qing Zhang; Christen L Mumaw; Nisha Raiker; Jeffrey Yu; Nieves Velez de Mendizabal; Laura S Haneline; Kent A Robertson; Jodi Skiles; Maribel Diaz-Ricart; Enric Carreras; Jamie Renbarger; Samir Hanash; Robert R Bies; Sophie Paczesny
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-11       Impact factor: 5.742

Review 2.  Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Authors:  Mitchell S Cairo; Kenneth R Cooke; Hillard M Lazarus; Nelson Chao
Journal:  Br J Haematol       Date:  2020-03-04       Impact factor: 6.998

3.  Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.

Authors:  J Inagaki; K Kurauchi; R Fukano; M Noguchi; J Okamura
Journal:  Bone Marrow Transplant       Date:  2016-07-04       Impact factor: 5.483

Review 4.  Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).

Authors:  Cathy Q Fan; James M Crawford
Journal:  J Clin Exp Hepatol       Date:  2014-10-30

5.  Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.

Authors:  Juliana Moura Nabarrete; Andrea Z Pereira; Adriana Garófolo; Adriana Seber; Angela Mandelli Venancio; Carlos Eduardo Setanni Grecco; Carmem Maria Sales Bonfim; Claudia Harumi Nakamura; Daieni Fernandes; Denise Johnsson Campos; Fernanda Luisa Ceragioli Oliveira; Flávia Krüger Cousseiro; Flávia Feijó Panico Rossi; Jocemara Gurmini; Karina Helena Canton Viani; Luciana Fernandes Guterres; Luiz Fernando Alves Lima Mantovani; Luiz Guilherme Darrigo Junior; Maria Isabel Brandão Pires E Albuquerque; Melina Brumatti; Mirella Aparecida Neves; Natália Duran; Neysimelia Costa Villela; Victor Gottardello Zecchin; Juliana Folloni Fernandes
Journal:  Einstein (Sao Paulo)       Date:  2021-12-10

Review 6.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

7.  Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Authors:  K Yakushijin; Y Atsuta; N Doki; A Yokota; H Kanamori; T Miyamoto; C Ohwada; K Miyamura; Y Nawa; M Kurokawa; I Mizuno; T Mori; M Onizuka; J Taguchi; T Ichinohe; H Yabe; Y Morishima; K Kato; R Suzuki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

Review 8.  Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.

Authors:  C Saillard; D Blaise; D Mokart
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

9.  Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.

Authors:  Xuan Wang; Wei Zhang; Ming Zhang; Feng Zhang; Jiangqiang Xiao; Qin Yin; Hao Han; Taishun Li; Ge Lin; Yuzheng Zhuge
Journal:  Hepatol Int       Date:  2022-01-12       Impact factor: 9.029

10.  Defibrotide for the treatment of severe hepatic sinusoidal obstruction syndrome: a single-centre experience.

Authors:  Laura Baladé Martínez; Marta Molina Cabezuelo; Elena Villamañan Bueno; Elena Rodríguez Martín; Alícia Herrero Ambrosio
Journal:  Eur J Hosp Pharm       Date:  2018-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.